key: cord-0785444-ydk1iay6
authors: Sneha, Latha M.; Tatapudi, Vahnita; Scott, Julius Xavier; Suman, Febi Renjitha; Gayathri, S. Sri; Jayaraman, Dhaarani
title: SARS‐CoV‐2 At diagnosis of acute lymphoblastic leukemia—Case series. To worry about COVID or leukemia? A developing country's perspective
date: 2021-05-18
journal: Pediatr Blood Cancer
DOI: 10.1002/pbc.29124
sha: 90448aaf1bd8e6682257c6b1f12df5e03564bc46
doc_id: 785444
cord_uid: ydk1iay6

nan

To the Editor:

The current published recommendations for management of pediatric cancer patients during coronavirus infection disease (COVID) pandemic emphasize protocol-based cancer therapy regimens. Milder disease of COVID-19 observed in pediatric population in relation to other age groups and potential curable nature of most pediatric malignancies formed the basis for these recommendations. 1 However, during the initial phase of pandemic, when the impact of COVID-19 infection among pediatric oncology patients was unknown, the management of concomitant COVID-19 infection in newly diagnosed acute lymphoblastic leukemia (ALL) was challenging. We report the management of three cases of newly diagnosed B-cell ALL who were found to be COVID positive at the time of diagnosis.

A 6-year-old girl was admitted with fever for 20 days with generalized lymphadenopathy and hepato splenomegaly. Blood tests showed hemoglobin 4.6 g/dl, WBC 4.2 × 10 9 /L, and platelets 0.46 × 10 9 /L. Peripheral smear showed 69% lymphoblasts. Renal function tests, liver function tests, and tumor lysis workup was normal. Diagnosis was confirmed by peripheral blood flow cytometry, which showed blast cells, compatible with B-cell ALL. During routine screening at admission, nasopharyngeal swab was positive for SARS-CoV-2.

A 5-year-old female child was admitted with complaints of multiple joint pain and swelling with generalized lymphadenopathy. Blood tests showed hemoglobin of 7.5 g/dl, total leukocyte count 6.1 × 10 9 /L, and platelets 0.35 × 10 9 /L. Peripheral smear showed 4% atypical lym- 

Early advice on managing children with cancer during the COVID-19 pandemic and a call for sharing experiences

Flash survey on severe acute respiratory syndrome coronavirus-2 infections in paediatric patients on anticancer treatment

Multicenter initial guidance on use of antivirals for children with COVID-19/SARS-CoV-2

Comment on: acute lymphoblastic leukemia onset in a 3-year-old child with COVID-19

Acute lymphoblastic leukemia onset in a 3-year-old child with COVID-19